
How the Conference Started
In 1957, Theodore Gleichman, in private
practice in Denver, approached Roger S. Mitchell, Chief of the Pulmonary Disease
Division and Director of the Webb-Waring Lung Institute with a proposal. His
idea was to establish a conference for the exchange of new ideas and
presentation of new research on emphysema and related topics. At that time,
emphysema was a poorly understood disease.
Together with Giles F. Filley and John R.(Jack)
Durrance the Aspen Emphysema Conference was planned. Funds for the first
conference in 1958, as well as the next ten, were readily obtainable from grants
from the National Institutes of Health. The proceedings of the 1958 Conference
were published as a special supplement to the American Review of Respiratory
Diseases. The conference was off to a good start.
In 1965, Tom Petty organized the Conference on therapy for
chronic obstructive pulmonary disease (COPD). This became a landmark conference
because it dealt, for the first time, with systematic care for "respiratory
cripples."
In 1980, Dr. Petty established the Aspen Lung Conference
Endowment Fund with contributions from former fellows, attendees, and some major
contributions from the pharmaceutical industry to help insure partial funding
for future conferences. In 1989, the conference was renamed in honor of Tom
Petty who has worked tirelessly over the years, organizing and chairing at least
eight of the conferences. Beginning with the 33rd Conference conducted in 1990,
the conference became known as the "Thomas L. Petty Aspen Lung
Conference".
The Aspen Conference is made unique by its multidisciplinary
format and international scope. It is an idea forum for both the established
scientists and in particular the young investigator, allowing them to present
their work in the atmosphere of a symposium in front of experts in the field.

Increased Need for Knowledge
The importance of gathering and disseminating
knowledge dealing with lung disease is accentuated when we realize that the
awareness of lung problems today is at the same stage hypertension was 20 years
ago. The need for rapid growth is further evident in the fact that at least 30
million people suffer from emphysema, asthma, and chronic bronchitis in the
United States alone. As many as 10 million are undiagnosed. Furthermore,
"respiratory cripples" - those people restricted in their ability to
earn a living - are growing in number. Knowledge is the key in the battle to
prevent and manage lung disease.
As many as 100,000 copies of the proceedings
are distributed annually throughout the world. The Conference continues to be a
tremendous source of knowledge, providing increasing insight into basic
mechanisms, diagnosis and management of pulmonary disease.
In the past, Dr. Petty raised the funds to
support the conferences from many different sources including industry,
foundations, lung associations, personal friends, and patients. Beginning in 1985,
Dr. Marvin Schwarz, Head of the Division of Pulmonary Sciences and Critical
Care Medicine took over the administrative management of the conference. In
February 2002, the Thomas L. Petty Aspen Lung Conference became a not-for-profit corporation. They continue each year to seek the support of industry to further
the traditions and scientific excellence of the Thomas
L. Petty Aspen Lung Conference.
Your tax deductible contribution will advance
knowledge and help lung care patients to receive the type of diagnosis and
management now available to patients suffering from hypertension, diabetes,
heart trouble and other diseases.
Please send your contribution made payable to:
Aspen Lung Conference
1414 S. Lima Street
Aurora, Colorado 80012-4127
Tax ID#: 84-1606032

Past Conferences
Emphysema & Chronic Bronchitis (1958)
Pulmonary Mechanics (1959)
Air Pollution (1960)
Asthma (1961)
Pulmonary Circulation (1962)
Adaptation to Atmosphere (1963)
Pathogenesis (1964)
Management of Emphysema & Chronic
Bronchitis (1965)
Current Research (1966-70)
Acid-Base & Blood Gas Transport (1971)
Asthma (1972)
Adult Respiratory Disease Syndrome (1973)
Basic Science & the Lung (1974)
Interstitial Lung Disease (1975)
The Pulmonary Circulation (1976)
Neuromuscular & Chemical Control of
Breathing (1977)
Immunology of the Lung (1978)
Chronic Obstructive Pulmonary Disease (Epidemiology,
Course & Prognosis, Intervention) (1979)
The Environment & the Lung (1980)
Bronchopulmonary Secretions & Fluids (1981)
Lung Defense, Injury & Repair (1982)
Emphysema--Revisited (1983)
Asthma (1984)
Interstitial Lung Diseases (1985)
Molecular & Cellular Biology of Lung Cancer
(1986)
Pulmonary Circulation and Pulmonary Hypertension (1987)
Infections and the Lung (1988)
Chronic Respiratory Failure (1989)
Mechanisms of Lung Repair (1990)
Epithelial Cell Biology and Airway Disease (1991)
Immunology of the Lung (1992)
Acute Lung Injury (1993)
Asthma: Structure & Function (1994)
Environmental Lung Disease:
Exposures & Mechanisms (1995)
Genes and Gene Therapy (1996)
Biology & Pathobiology of the Lung
Circulation (1997)
Acute Lung Injury (1998)
Mechanisms of COPD (1999)
Mechanisms of Pulmonary Fibrosis (2000)
Pulmonary Genetics, Genomics and Gene Therapy (2001)
Asthma in the New Millennium (2002)
Lung Cancer (2003)
Cellular and Molecular Pathobiology of Pulmonary Hypertension (2004)
Pathobiology of COPD (2005)
Immunologic Diseases of the Lung (2006)

Future Conferences
Lung Injury and Repair (2007)
Asthma: Insights and Expections (2008)
Environmental/Occupational Lung Disease (2009)

|